Formulation and evaluation of rebampide extended release tablets
Keywords:
Rebampide, HPMC (K4M), HPMC K100MAbstract
The aim of the present study was to develop Extended-release formulation of Rebampide to maintain constant therapeutic levels of the drug for over 12 hrs. Carbopol 71 G, HPMC K100M, HPMC (K4M) were employed as polymers. All the formulations were passed various physicochemical evaluation parameters and they were found to be within limits. Whereas from the dissolution studies it was evident that the formulation (F6) showed better and desired drug release pattern i.e., 98.85% in 12 hours. It contains the HPMC (K4M) as Extended-release material. It followed peppas release kinetics mechanism.
Published
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

